SynthesisJAMA network open2025
Mortality Risk Prediction Models for People With Kidney Failure: A Systematic Review.
Synthesis in JAMA network open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Comparison the clinical outcomes of intravenous and subcutaneous erythropoietin administration in hemodialysis patients of plateau regions.BMC nephrology · 2026Article
- Charlson comorbidity index and palliative performance scale predict prognosis in dialysis patients: a retrospective cohort study.BMC palliative care · 2026Article
- Circulating Humanin Improves the Prognostic Accuracy of Cardiovascular Risk Models in Chronic Hemodialysis Patients.Cardiorenal medicine · 2026Article
- Kidney-therapy decision-making among older adults and caregivers: treatment beliefs, prognostic information, and health priorities.BMC nephrology · 2025Article
- Can we predict mortality of older patients with advanced chronic kidney disease?Internal medicine journal · 2025Article
- Development and Validation of Survival Scores and the Assessment of Spatial Trends in End-Stage Kidney Disease Outcomes.Research square · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
Importance: People with kidney failure have a high risk of death and poor quality of life. Mortality risk prediction models may help them decide which form of treatment they prefer. Objective: To systematically review the quality of existing mortality prediction models for people with kidney failure and assess whether they can be applied in clinical practice. Evidence Review: MEDLINE, Embase, and the Cochrane Library were searched for studies published between January 1, 2004, and September 30, 2024. Studies were included if they created or evaluated mortality prediction models for people who developed kidney failure, whether treated or not treated with kidney replacement with hemodialysis or peritoneal dialysis. Studies including exclusively kidney transplant recipients were excluded. Two reviewers independently extracted data and graded each study at low, high, or unclear risk of bias and applicability using recommended checklists and tools. Reviewers used the Prediction Model Risk of Bias Assessment Tool and followed prespecified questions about study design, prediction framework, modeling algorithm, performance evaluation, and model deployment. Analyses were completed between January and October 2024. Findings: A total of 7184 unique abstracts were screened for eligibility. Of these, 77 were selected for full-text review, and 50 studies that created all-cause mortality prediction models were included, with 2 963 157 total participants, who had a median (range) age of 64 (52-81) years. Studies had a median (range) proportion of women of 42% (2%-54%). Included studies were at high risk of bias due to inadequate selection of study population (27 studies [54%]), shortcomings in methods of measurement of predictors (15 [30%]) and outcome (12 [24%]), and flaws in the analysis strategy (50 [100%]). Concerns for applicability were also high, as study participants (31 [62%]), predictors (17 [34%]), and outcome (5 [10%]) did not fit the intended target clinical setting. One study (2%) reported decision curve analysis, and 15 (30%) included a tool to enhance model usability. Conclusions and Relevance: According to this systematic review of 50 studies, published mortality prediction models were at high risk of bias and had applicability concerns for clinical practice. New mortality prediction models are needed to inform treatment decisions in people with kidney failure.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.